Administrative LawFDAFeaturedPublic Health
November 11, 2025By Bar Sadeh
In September 2025, the European Union (“EU”) banned a key ingredient in gel nail polish, sparking headlines that gel manicures are now illegal in Europe.[i] Meanwhile, the product remains available on the market and in salons across the United States. Why the discrepancy? What does this reveal about each system’s approach to cosmetic safety? It […]
Read More
Administrative LawFDAFeaturedPharmaceuticalsPublic Health
October 24, 2025By Ciara Maytan
Ozempic is no longer just a prescription—it has become a cultural phenomenon. From Hollywood red carpets to TikTok feeds, Glucagon-Like Peptide-1 (“GLP-1”) drugs like Ozempic, Wegovy, and Mounjaro are hailed as “miracle” fixes for weight loss. Yet, behind the hype lies an uncomfortable truth: These drugs surged into widespread use quickly, and patients are now […]
Read More
FDAFeaturedFederal Law
March 3, 2025By Delaney Nix
Welcome to the United States (“U.S.”), one of the wealthiest nations in the world but far from the healthiest. With an astounding 40% of adults having obesity, the U.S. has the highest obesity rate among high-income countries and also leads the way in prevalence for diabetes and high plasma glucose levels.[i] One in five children […]
Read More
FDAFeaturedFederal LawSupreme Court
February 5, 2025By Stephanie Blanco
Under the Family Smoking Prevention and Tobacco Control Act (the “Act”), the Federal Drug Administration (“FDA”), responsible for protecting and promoting public health and safety, regulates the manufacture and production of tobacco products, including e-cigarettes.[i] The Act provides the FDA with agency regulatory authority to approve the sale of tobacco products if the applicant […]
Read More
